Mimedx (MDXG) Operating Margin (2016 - 2025)
Historic Operating Margin for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to 19.51%.
- Mimedx's Operating Margin rose 62300.0% to 19.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.69%, marking a year-over-year decrease of 47700.0%. This contributed to the annual value of 16.87% for FY2024, which is 53300.0% up from last year.
- According to the latest figures from Q3 2025, Mimedx's Operating Margin is 19.51%, which was up 62300.0% from 12.55% recorded in Q2 2025.
- In the past 5 years, Mimedx's Operating Margin ranged from a high of 26.89% in Q2 2024 and a low of 15.79% during Q1 2022
- Over the past 5 years, Mimedx's median Operating Margin value was 11.9% (recorded in 2024), while the average stood at 6.14%.
- In the last 5 years, Mimedx's Operating Margin skyrocketed by 277500bps in 2023 and then crashed by -143500bps in 2025.
- Quarter analysis of 5 years shows Mimedx's Operating Margin stood at 2.53% in 2021, then soared by 501bps to 15.21% in 2022, then rose by 17bps to 17.84% in 2023, then crashed by -33bps to 11.9% in 2024, then soared by 64bps to 19.51% in 2025.
- Its last three reported values are 19.51% in Q3 2025, 12.55% for Q2 2025, and 9.35% during Q1 2025.